NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 47 filers reported holding NEUBASE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 25 | -93.5% | 0.00% | – |
| Q3 2021 | $1,000 | -99.6% | 385 | -99.2% | 0.00% | – |
| Q2 2021 | $231,000 | -39.1% | 48,311 | -5.7% | 0.00% | – |
| Q1 2021 | $379,000 | +11.5% | 51,222 | +5.4% | 0.00% | – |
| Q4 2020 | $340,000 | +335.9% | 48,581 | +370.4% | 0.00% | – |
| Q3 2020 | $78,000 | -31.0% | 10,328 | -19.9% | 0.00% | – |
| Q2 2020 | $113,000 | +14.1% | 12,899 | -6.2% | 0.00% | – |
| Q4 2019 | $99,000 | – | 13,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 906,445 | $3,272,000 | 1.04% |
| Greenlight Capital | 2,727,027 | $9,844,000 | 0.66% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 407,500 | $1,471,000 | 0.54% |
| CM Management, LLC | 75,000 | $271,000 | 0.20% |
| Stonepine Capital Management, LLC | 109,742 | $396,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 351,178 | $1,268,000 | 0.13% |
| PERKINS CAPITAL MANAGEMENT INC | 21,000 | $76,000 | 0.05% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $1,123,000 | 0.03% |
| Polar Asset Management Partners Inc. | 634,618 | $2,291,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,250,000 | $4,513,000 | 0.02% |